Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 89Terminated 15Recruiting 9Active not recruiting 9Withdrawn 5Unknown 2Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 34Other hematologic neoplasm 19Lymphoid 10Plasma cell 8Sarcoma 4Genitourinary 3Dermatologic 3Gynecologic 2Classical hematology 2CNS 2Other neoplasm 1Breast 1

Conditions

Neoplasms 22Venous Thromboembolism 20Febrile Neutropenia 20Anemia 19Thrombocytopenia 14Myelodysplastic Syndromes 14Leukemia, Myeloid, Acute 13Lymphoma 11Leukemia 11Anemia, Aplastic 10Colorectal Neoplasms 9Anemia, Refractory, with Excess of Blasts 9Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Anemia, Iron-Deficiency 7Neutropenia 6Multiple Myeloma 6Anemia, Sickle Cell 6Ovarian Neoplasms 5Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Hematologic Neoplasms 5Fanconi Anemia, Complementation Group D1 5Hemophilia A 4Osteoporosis 3Lung Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Depression 3Chemotherapy-induced Thrombocytopenia 3

Interventions

Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Myeloproliferative Disorders × Classical hematology × Clear all
NCT04060485 2019-08-19

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

National Taiwan University Hospital

Unknown
1,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT00043134 2010-04-13

Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
220 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡